サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1701949

臨床栄養市場：製品別、投与経路別、用途別、エンドユーザー別、地域別、2025-2033年

Clinical Nutrition Market Report by Product, Route of Administration, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
臨床栄養市場：製品別、投与経路別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床栄養市場の世界市場規模は2024年に558億米ドルに達しました。今後、市場は2033年までに1,046億米ドルに達し、2025年から2033年にかけて7.2％の成長率（CAGR）を示すと予想されます。市場を牽引している要因には、世界の慢性疾患の蔓延と高齢化の進展、ヘルスケアにおける栄養の重要性に対する意識の高まり、個別化栄養や医療栄養におけるさまざまな技術的進歩、食事パターンや生活習慣の変化など、さまざまなものがあります。

臨床栄養は、医療栄養療法を採用することで疾病管理に焦点を当てる栄養科学の専門分野を指します。また、必須栄養素の不足によって起こる慢性疾患に関連する栄養および代謝状態の診断と予防も含まれます。一般的に利用できる臨床栄養の種類には、乳児栄養、経腸栄養、非経口栄養などがあります。臨床栄養は、栄養不良の結果を軽減し、疾患治療への反応を高め、免疫レベルを高め、摂取能力を高めるなど、多くの利点を提供します。

臨床栄養市場傾向：

肥満、高血圧、異常なコレステロール値などのリスクを高める代謝性疾患の有病率の上昇が、主に世界の臨床栄養市場を牽引しています。さらに、慢性的な胃腸疾患にかかりやすい老年人口の拡大も、在宅医療モデルにおける臨床栄養の需要を促進しています。これに加えて、早産件数の増加と小児医療分野における臨床栄養のニーズの高まりが、市場の成長をさらに促進しています。さらに、医療インフラの継続的なアップグレードと、疾病管理のための臨床栄養手順への容易なアクセスに関する政府の意識向上プログラムの導入が、重要な成長誘発要因として作用しています。これとは別に、COVID-19の大流行では、コロナウイルス感染のリスクを防ぐために、臨床栄養を含む免疫力を高める代替品に対する需要が大幅に増加しています。感染の結果、重度の食欲不振、無嗅覚性味覚障害、下痢などが生じ、病気に関連した栄養失調を引き起こす可能性があります。臨床栄養は、COVID-19患者の免疫防御の改善とともに、急性栄養失調とタンパク質欠乏症の治療に役立ちます。さらに、脂質エマルションの最適化、液体形態の経口臨床栄養製剤の導入など、臨床栄養ソリューションにおける重要な技術革新が、予測期間にわたって世界の臨床栄養市場を牽引すると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の臨床栄養市場の市場規模は？
  • 2025-2033年における臨床栄養市場の世界市場予測成長率は？
  • 世界の臨床栄養市場を牽引する主要因は何か？
  • 世界の臨床栄養市場に対するCOVID-19の影響は？
  • 世界の臨床栄養市場の製品別内訳は？
  • 世界の臨床栄養市場の投与経路別の内訳は？
  • 世界の臨床栄養市場のエンドユーザー別の内訳は？
  • 世界の臨床栄養市場における主要地域は？
  • 世界の臨床栄養市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の臨床栄養市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 乳児栄養
  • 非経口栄養
  • 経腸栄養

第7章 市場内訳：投与経路別

  • 経口
  • 経腸
  • 非経口

第8章 市場内訳：用途別

  • がん
  • 栄養失調
  • 代謝障害
  • 胃腸障害
  • 神経疾患
  • その他

第9章 市場内訳：エンドユーザー別

  • 小児
  • 成人
  • 高齢者

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • BASF SE
    • Baxter International Inc.
    • Danone S.A.
    • Fresenius SE & Co. KGaA
    • Grifols S.A.
    • Koninklijke DSM N.V.
    • Meiji Holdings Co. Ltd.
    • Nestle S.A.
    • Perrigo Company plc
    • Reckitt Benckiser Group PLC
図表

List of Figures

  • Figure 1: Global: Clinical Nutrition Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Nutrition Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Clinical Nutrition Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Clinical Nutrition Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Clinical Nutrition Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Clinical Nutrition Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Clinical Nutrition Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Clinical Nutrition Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Clinical Nutrition (Infant Nutrition) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Clinical Nutrition (Infant Nutrition) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Clinical Nutrition (Parental Nutrition) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Clinical Nutrition (Parental Nutrition) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Clinical Nutrition (Enteral Nutrition) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Clinical Nutrition (Enteral Nutrition) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Clinical Nutrition (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Clinical Nutrition (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Clinical Nutrition (Enteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Clinical Nutrition (Enteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Clinical Nutrition (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Clinical Nutrition (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Clinical Nutrition (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Clinical Nutrition (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Clinical Nutrition (Malnutrition) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Clinical Nutrition (Malnutrition) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Clinical Nutrition (Metabolic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Clinical Nutrition (Metabolic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Clinical Nutrition (Gastrointestinal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Clinical Nutrition (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Clinical Nutrition (Neurological Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Clinical Nutrition (Neurological Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Clinical Nutrition (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Clinical Nutrition (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Clinical Nutrition (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Clinical Nutrition (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Clinical Nutrition (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Clinical Nutrition (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Clinical Nutrition (Geriatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Clinical Nutrition (Geriatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: North America: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: United States: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: United States: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Canada: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Canada: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Asia-Pacific: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Asia-Pacific: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: China: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: China: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Japan: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Japan: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: India: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: India: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: South Korea: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: South Korea: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Australia: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Australia: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Indonesia: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Indonesia: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Europe: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Europe: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Germany: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Germany: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: France: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: France: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: United Kingdom: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: United Kingdom: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Italy: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Italy: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Spain: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Spain: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Russia: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Russia: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Latin America: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Latin America: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Brazil: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Brazil: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Mexico: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Mexico: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Middle East and Africa: Clinical Nutrition Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Middle East and Africa: Clinical Nutrition Market: Breakup by Country (in %), 2024
  • Figure 87: Middle East and Africa: Clinical Nutrition Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Clinical Nutrition Industry: SWOT Analysis
  • Figure 89: Global: Clinical Nutrition Industry: Value Chain Analysis
  • Figure 90: Global: Clinical Nutrition Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Nutrition Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Clinical Nutrition Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Clinical Nutrition Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Clinical Nutrition Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Clinical Nutrition Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Clinical Nutrition Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Clinical Nutrition Market: Competitive Structure
  • Table 8: Global: Clinical Nutrition Market: Key Players
目次
Product Code: SR112025A5995

The global clinical nutrition market size reached USD 55.8 Billion in 2024. Looking forward, the market is expected to reach USD 104.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. There are various factors that are driving the market, which include increasing prevalence of chronic diseases and aging population worldwide, rising awareness about the importance of nutrition in healthcare, various technological advancements in personalized nutrition and medical nutrition, and changing dietary patterns and lifestyle habits.

Clinical nutrition refers to a specialized field of nutrition science that focuses on disease management by adopting medical nutrition therapies. It also includes the diagnosis and prevention of nutritional and metabolic conditions associated with chronic disorders that occur due to the lack of essential nutrients. Some of the commonly available types of clinical nutrition include infant nutrition, enteral nutrition, and parenteral nutrition. Clinical nutrition offers numerous benefits in reducing the consequences of malnutrition, enhancing the response to disease treatment, boosting immunity levels, enhancing ingestion abilities, etc.

Clinical Nutrition Market Trends:

The rising prevalence of metabolic disorders that increase the risk of obesity, high blood pressure, abnormal cholesterol levels, etc., is primarily driving the global clinical nutrition market. Moreover, the expanding geriatric population, who are more prone to chronic gastrointestinal ailments, is also propelling the demand for clinical nutrition in the home healthcare model. Besides this, elevating number of preterm births coupled with the inflating need for clinical nutrition in the pediatric medicine segment is further augmenting the market growth. Additionally, continuous upgradation of healthcare infrastructures and the introduction of government awareness programs regarding the easy accessibility to clinical nutrition procedures for disease management are acting as significant growth-inducing factors. Apart from this, in the COVID-19 pandemic, the demand for immunity-boosting alternatives, including clinical nutrition, has significantly increased to prevent the risk of coronavirus infection. The infection results in severe lack of appetite, anosmia dysgeusia, diarrhea, etc., which can lead to disease-related malnutrition. Clinical nutrition aid in treating acute malnutrition and protein deficiency along with improving immune defenses in COVID-19 patients. Moreover, significant innovations in clinical nutrition solutions, including lipid emulsions optimization, and the introduction of oral clinical nutrition formula in liquid form, are expected to drive the global clinical nutrition market over the forecasted period.

Key Market Segmentation:

Breakup by Product:

  • Infant Nutrition
  • Parental Nutrition
  • Enteral Nutrition

Breakup by Route of Administration:

  • Oral
  • Enteral
  • Parenteral

Breakup by Application:

  • Cancer
  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

Breakup by End User:

  • Pediatric
  • Adults
  • Geriatric

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestle S.A., Perrigo Company plc and Reckitt Benckiser Group PLC.

Key Questions Answered in This Report

  • 1.What was the size of the global clinical nutrition market in 2024?
  • 2.What is the expected growth rate of the global clinical nutrition market during 2025-2033?
  • 3.What are the key factors driving the global clinical nutrition market?
  • 4.What has been the impact of COVID-19 on the global clinical nutrition market?
  • 5.What is the breakup of the global clinical nutrition market based on the product?
  • 6.What is the breakup of the global clinical nutrition market based on the route of administration?
  • 7.What is the breakup of the global clinical nutrition market based on the end user?
  • 8.What are the key regions in the global clinical nutrition market?
  • 9.Who are the key players/companies in the global clinical nutrition market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Nutrition Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Infant Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Parental Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Enteral Nutrition
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Enteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Parenteral
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Malnutrition
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Metabolic Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Gastrointestinal Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Neurological Disorders
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pediatric
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Adults
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Geriatric
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 BASF SE
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Baxter International Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danone S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Fresenius SE & Co. KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Grifols S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meiji Holdings Co. Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Nestle S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Perrigo Company plc
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Reckitt Benckiser Group PLC
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis